122P Primary Results and Biomarker Analysis from PREDIX LumB: A Prospective Randomized Phase II Trial Investigating Sequence of Neoadjuvant Chemotherapy and Palbociclib/endocrine Therapy for Luminal Breast Cancer
ESMO Open(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要